Navigation Links
Shellfish and inkjet printers may hold key to faster healing from surgeries
Date:3/17/2009

Using the natural glue that marine mussels use to stick to rocks, and a variation on the inkjet printer, a team of researchers led by North Carolina State University has devised a new way of making medical adhesives that could replace traditional sutures and result in less scarring, faster recovery times and increased precision for exacting operations such as eye surgery.

Traditionally, there have been two ways to join tissue together in the wake of a surgery: sutures and synthetic adhesives. Sutures work well, but require enormous skill and longer operating times. Additionally, the use of sutures is associated with a number of surgical complications, including discomfort, infection and inflammation. Synthetic adhesives are also widely used, but they are the source of increasing concerns over their toxicological and environmental effects. One such concern with some synthetic medical adhesives is that because they are not biodegradable they do not break down in the body and therefore may cause inflammation, tissue damage, or other problems.

But new research shows that adhesive proteins found in the "glue" produced by marine mussels may be used in place of the synthetic adhesives without these concerns, because they are non-toxic and biodegradable, according to study co-author Dr. Roger Narayan. In addition, the mussel proteins can be placed in solution and applied using inkjet technology to create customized medical adhesives, which may have a host of applications. For example, Narayan says this technique may "significantly improve wound repair in eye surgery, wound closure and fracture fixation." Narayan is an associate professor in the joint biomedical engineering department of NC State and the University of North Carolina at Chapel Hill.

"This is an improved way of joining tissues," Narayan says, "because the use of the inkjet technology gives you greater control over the placement of the adhesive. This helps ensure that the tissu
'/>"/>

Contact: Matt Shipman
matt_shipman@ncsu.edu
919-515-6386
North Carolina State University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Pacific shellfish ready to invade Atlantic
2. Saltwater sleuths: Seeking clues to help determine the ages of fish and shellfish populations
3. Underwater microscope helps prevent shellfish poisoning along Gulf Coast of Texas
4. Breast cancer research and inkjet tissue printing get NSF boost
5. New open-source software permits faster desktop computer simulations of molecular motion
6. Ocean growing more acidic faster than once thought
7. New type of vaccines deliver stronger and faster immune response
8. Emissions rising faster this decade than last
9. TGen investigators devise faster, cheaper way of analyzing the human genome
10. Big-brained animals evolve faster
11. Wasps and bumble bees heat up, fly faster with protein-rich food

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ital to your health as what you eat, found researc... Their experiments in mice revealed that the daily...verthe body,s metabolic clearinghouseis mostly con...dian clock as conventional wisdom had it. , "If...umber of genes completely independent of the circa...
(Date:11/24/2009)...es from collapsing have been true life-savers. But...ed -- once the arteries are strengthened, they bec... but to leave them in place. , Prof. Meital Zilb...dical Engineering has developed a new patent-pendi... needed, then dissolves. , "Our new composite fi...
(Date:11/24/2009)...debate. A high-profile study a few years ago sugge...on from trees and leaves, evidence for a very clos...ems. , But new research from the University of W...ae provide a much richer diet for fish and other a...week in the Proceedings of the National Academy o...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 1Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 2Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 3Go to the doctor 3F Only if Im really sick 52314 1Go to the doctor 3F Only if Im really sick 52314 2Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 1Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 2Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 3
...ngs about the causes of mad cow disease show that ...also in the genes of cattle," said Juergen A. Rich...edicine and Pathobiology at Kansas State Universit...al years ago, Richt said, it was thought that the ...thy -- also called BSE or mad cow disease -- was a...
...Stevens Institute of Technology has been awarded a...e project, "MRI: Acquisition of an Inductively Cou...abrication." The Stevens team includes Yong Shi, t...gineering department; Stefan Strauf, a Professor t...e Professor in the Mechanical Engineering departme...
...t Service Southern Research Station (SRS) today an...t Disturbances: Wildfires, Storms, and Invasive Sp...ffers a synthesis of new approaches to understandi...s. , The Economics of Forest Disturbances is th...e framework for analyzing the economic effects of ...
Other Biology News:K-State professor's USDA research shows mad cow disease also caused by genetic mutation 2NSF awards two grants to Stevens for nano/micro device fabrication and nano sensor development 2Book breaks new ground in the study of economics and forest threats management 2
(Date:11/24/2009)...EYKJAVIK, Iceland, November 24 /PRNewswire-FirstCa... announced the approval of all of its,"first day" ...ict of Delaware,(the "Bankruptcy Court"). deCODE l...er Chapter 11 of the United States Bankruptcy Code...issued by the Bankruptcy Court allow the company t...
(Date:11/24/2009)... Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolaxy ann...ation (SFDA) has approved the,investigational new ...t,(Nodlin), an innovative insulin formulation to t... initiate its first phase I clinical study. ,... blood glucose and poor,metabolism. The complicati...
(Date:11/24/2009)...cacy endpoint has been met for patients with advan..., QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - ...the "Company"), a global biopharmaceutical company...announced positive efficacy data from a Phase 2 st... AEZS-108 (formerly AN-152), in patients with adva...
(Date:11/24/2009).... 24, 2009 Arena Pharmac...that the company is scheduled to present at the Pi...December 1, 2009 at 11:30 a.m. Eastern Time (8:30 ... New York City. Jack Lief, Arena,s President and C... overview of the company, including its clinical d...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
... 12 Anthera Pharmaceuticals, Inc., a,privately he...mmatory drugs,announced today that it has complete...urrent Acute coronary events with Near-term Cardio...designed to examine the impact of,varespladib (A-0...of an Acute,Coronary Syndrome (ACS) event. , "...
... Pharmasset, Inc. (Nasdaq: VRUS ) announced toda...have agreed with the FDA on the final design for a... of hepatitis C (HCV), slated to initiate in the f...at R7128 is advancing into a large phase 2b trial,...ief Medical Officer. "R7128 is the most advanced n...
...nuary 12 , - Reflects Strong International Gr...ding IP Management Specialist and Legal Support Se...llectual property,( http://www.cpaglobal.com ) (IP...outsourced legal support services, has today marke...ew brand worldwide. , Founded in 1969 as a spe...
Other Biology Technology:Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial 2Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial 3Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 2Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 3Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 4Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 5CPA Global Marks 40th Anniversary With Launch of New Brand 2CPA Global Marks 40th Anniversary With Launch of New Brand 3
Rat IgG2b Clone: A95-1, Allophycocyanin Conjugated/Tagged from BD Biosciences Pharmingen
Rabbit Anti-Human Sphingosine 1-phosphate receptor Edg-1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Rat Albumin EIA Kit from Cayman Chemical
CMV IgM ELISA Kit, Single from Bio-Quant Inc.
Biology Products: